5.95
-0.05
(-0.83%)
At close: 8:19:31 AM GMT+2
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Joseph Todisco MBA | CEO & Director | 943.06k | -- | 1976 |
| Dr. Matthew T. David M.D. | Executive VP & CFO | 525.91k | -- | 1977 |
| Ms. Erin Mistry | Executive VP & Chief Commercial Officer | 494.47k | -- | 1982 |
| Ms. Elizabeth Masson-Hurlburt B.A. | Executive VP and Chief Clinical Strategy & Operations Officer | 474.52k | -- | 1979 |
| Ms. Kaufman Beth Zelnick Esq. | EVP, Chief Legal, Compliance Officer & Corporate Secretary | -- | -- | 1961 |
| Donna Ucci | Senior VP & Head of Global Quality | -- | -- | -- |
| Dr. Tushar Mukherjee | Senior VP & Head of Technical Operations | -- | -- | -- |
CorMedix Inc.
300 Connell Drive
Suite 4200
Berkeley Heights, NJ 07922
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 64
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Corporate Governance
CorMedix Inc.’s ISS Governance QualityScore as of April 1, 2025 is 5. The pillar scores are Audit: 6; Board: 5; Shareholder Rights: 1; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 7, 2025 at 12:30 PM UTC - May 12, 2025 at 12:30 PM UTC
CorMedix Inc. Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
ARDX.MX Ardelyx, Inc.
105.50
0.00%
B9A.F BioArctic AB (publ)
14.93
+1.50%
RPD.MU Royalty Pharma plc
28.20
0.00%
2HA.F Spero Therapeutics, Inc.
0.5290
+6.55%
05Y.MU Vivoryon Therapeutics NV
1.8260
-0.87%
PROT Proteonomix, Inc.
0.0000
-90.00%
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+12.29%
HQ1.MU Oruka Therapeutics Inc. R
6.65
+3.91%
7PO.F Poxel S.A.
0.5090
-3.96%
P0F.F Egetis Therapeutics AB (publ)
0.3100
-5.20%